These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1924427)

  • 21. Haemodynamic effects during treatment of sepsis and septic shock with immunoglobulins and plasma-pheresis.
    Werdan K; Pilz G; Kääb S
    Prog Clin Biol Res; 1989; 308():1025-30. PubMed ID: 2780684
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapy of gram-negative sepsis in man with anti-endotoxin antibodies: a review.
    Wortel CH; Ziegler EJ; van Deventer SJ
    Prog Clin Biol Res; 1991; 367():161-78. PubMed ID: 1924425
    [No Abstract]   [Full Text] [Related]  

  • 23. NO in septic shock: good, bad or ugly? Learning from iNOS knockouts.
    Gross SS; Kilbourn RG; Griffith OW
    Trends Microbiol; 1996 Feb; 4(2):47-9. PubMed ID: 8820564
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of septic shock: new approaches.
    Baumgartner JD; Eggimann P; Glauser MP
    Curr Clin Top Infect Dis; 1992; 12():165-87. PubMed ID: 1642798
    [No Abstract]   [Full Text] [Related]  

  • 25. The treatment of gram-negative bacteremia and shock.
    Wolff SM
    N Engl J Med; 1982 Nov; 307(20):1267-8. PubMed ID: 7133058
    [No Abstract]   [Full Text] [Related]  

  • 26. Perioperative TNF alpha and IL-6 concentrations correlate with septic state, organ function, and APACHE II scores in intra-abdominal infection.
    Függer R; Zadrobilek E; Götzinger P; Klimann S; Rogy M; Winkler S; Andel H; Mittelböck M; Roth E; Schulz F
    Eur J Surg; 1993 Oct; 159(10):525-9. PubMed ID: 8286509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoprophylaxis and immunotherapy of Gram-negative infections in the immunocompromised host.
    Glauser MP; McCutchan JA; Ziegler E
    Clin Haematol; 1984 Oct; 13(3):549-55. PubMed ID: 6388931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotherapy in gram-negative bacterial infections.
    Lugowski C
    Acta Biochim Pol; 1995; 42(1):19-24. PubMed ID: 7653155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of IgM and IgA-enriched immunoglobulins in the treatment of severe sepsis and septic shock. Clinical experience.
    Berlot G; Dimastromatteo G
    Minerva Anestesiol; 2004 Oct; 70(10):739-43; 743-5. PubMed ID: 15516885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of anti-tumor necrosis factor-alpha and interleukin-10 in protecting murine neonates from Escherichia coli sepsis.
    Lally KP; Cruz E; Xue H
    J Pediatr Surg; 2000 Jun; 35(6):852-4; discussion 855. PubMed ID: 10873025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of septic shock with antibodies to tumour necrosis factor.
    Cohen J; Exley AR
    Schweiz Med Wochenschr; 1993 Mar; 123(11):492-6. PubMed ID: 8475356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbiologic findings and correlations with serum tumor necrosis factor-alpha in patients with severe sepsis and septic shock.
    Cohen J; Abraham E
    J Infect Dis; 1999 Jul; 180(1):116-21. PubMed ID: 10353869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of gram-negative bacteremia with antiserum to core glycolipid II. A controlled trial of antiserum in patients with bacteremia.
    McCutchan JA; Ziegler EJ; Braude AI
    Eur J Cancer (1965); 1979; 15 Suppl():77-80. PubMed ID: 397064
    [No Abstract]   [Full Text] [Related]  

  • 34. IFN-gamma involvement in the severity of gram-negative infections in mice.
    Kohler J; Heumann D; Garotta G; LeRoy D; Bailat S; Barras C; Baumgartner JD; Glauser MP
    J Immunol; 1993 Jul; 151(2):916-21. PubMed ID: 8335919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ablation of the sympathetic nervous system decreases gram-negative and increases gram-positive bacterial dissemination: key roles for tumor necrosis factor/phagocytes and interleukin-4/lymphocytes.
    Straub RH; Pongratz G; Weidler C; Linde HJ; Kirschning CJ; Glück T; Schölmerich J; Falk W
    J Infect Dis; 2005 Aug; 192(4):560-72. PubMed ID: 16028124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
    Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
    Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-alpha-induced apoptosis.
    Hiromatsu T; Yajima T; Matsuguchi T; Nishimura H; Wajjwalku W; Arai T; Nimura Y; Yoshikai Y
    J Infect Dis; 2003 May; 187(9):1442-51. PubMed ID: 12717626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary artery catheterisation in septic shock. Indications; therapeutic and prognostic implications.
    Groeneveld AB; Thijs LG
    Clin Intensive Care; 1990; 1(3):111-5. PubMed ID: 10149073
    [No Abstract]   [Full Text] [Related]  

  • 39. Endotoxin-based molecular strategies for the prevention and treatment of gram-negative sepsis and septic shock.
    Pollack M; Ohl CA
    Curr Top Microbiol Immunol; 1996; 216():275-97. PubMed ID: 8791745
    [No Abstract]   [Full Text] [Related]  

  • 40. Pathophysiology of septic shock and implications for therapy.
    Barron RL
    Clin Pharm; 1993 Nov; 12(11):829-45. PubMed ID: 8161370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.